Rights and permissions
About this article
Cite this article
Chakradhar, S. Insurance companies are slow to cover next-generation sequencing. Nat Med 21, 204–205 (2015). https://doi.org/10.1038/nm0315-204
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0315-204
- Springer Nature America, Inc.
This article is cited by
-
Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Aging Clinical and Experimental Research (2019)
-
The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients
Molecular Diagnosis & Therapy (2017)
-
Was it worth it? Patients’ perspectives on the perceived value of genomic-based individualized medicine
Journal of Community Genetics (2016)